Estimation of HOMA-IR and Triglyceride-Glucose Index in Single Females with PCOS
DOI:
https://doi.org/10.24086/cuesj.v10n1y2026.pp18-23Keywords:
Polycystic ovarian syndrome, homeostatic model assessment for insulin resistance, triglyceride-glucose index, insulin resistanceAbstract
This study aims to estimate insulin resistance (IR) in single females with polycystic ovarian syndrome. A cross-sectional study was designed to assess the insulin hormone, blood glucose level, IR biomarker, triglyceride-glucose index, serum high-density lipoprotein, and triglyceride. The present included 45 single female participants whom a specialist gynecologist had previously diagnosed. Statistically, Females following a healthy diet showed a non-significant decrease in homeostatic model assessment for IR (HOMA-IR) and a fasting glucose-to-insulin ratio when compared with non-dieters. Regarding the menstrual cycle, the triglyceride-glucose index (a measure of IR) was considerably higher in females with irregular menstrual cycles (P ≤ 0.05) than in those with regular cycles. A significant positive (direct) correlation was observed between HOMA-IR and the triglyceride-Glucose (TyG) index among single females. This study indicated a strong positive correlation between HOMA-IR and the Triglyceride-Glucose Index among single female patients. In conclusion, a balanced diet is crucial for mitigating IR in this condition. Unusual menstruation was closely linked to poor metabolic profiles, such as increased IR and dyslipidemia.
Downloads
References
J. Dong and D. A. Rees. Polycystic ovary syndrome: Pathophysiology and therapeutic opportunities. BMJ Medicine, vol. 2, no. 1, p. e000548, 2023. DOI: https://doi.org/10.1136/bmjmed-2023-000548
2. J. Yang and C. Chen. Hormonal changes in PCOS. Journal of Endocrinology, vol. 261, no. 1, p. e230342, 2024. DOI: https://doi.org/10.1530/JOE-23-0342
3. S. Siddiqui, S. Mateen, R. Ahmad and S. Moin. A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS). Journal of Assisted Reproduction and Genetics, vol. 39, no. 11, pp. 2439-2473, 2022. DOI: https://doi.org/10.1007/s10815-022-02625-7
4. J. P. Christ and M. I. Cedars. Current guidelines for diagnosing PCOS. Diagnostics (Basel), vol. 13, no. 6, p. 1113, 2023. DOI: https://doi.org/10.3390/diagnostics13061113
5. A. Joshi. PCOS stratification for precision diagnostics and treatment. Frontiers in Cell and Developmental Biology, vol. 12, p. 1358755, 2024. DOI: https://doi.org/10.3389/fcell.2024.1358755
6. S. H. Lee, S. Y. Park and C. S. Choi. Insulin resistance: From mechanisms to therapeutic strategies. Diabetes and Metabolism Journal, vol. 46, no. 1, pp. 15-37, 2022. DOI: https://doi.org/10.4093/dmj.2021.0280
7. L. Szablewski. Changes in cells associated with insulin resistance. International Journal of Molecular Sciences, vol. 25, no. 4, p. 2397, 2024. DOI: https://doi.org/10.3390/ijms25042397
8. H. Majid, Q. Masood and A. H. Khan. Homeostatic model assessment for insulin resistance (HOMA-IR): A better marker for evaluating insulin resistance than fasting insulin in women with polycystic ovarian syndrome. Journal of the College of Physicians and Surgeons Pakistan, vol. 27, no. 3, pp. 123-126, 2017.
9. Y. Zheng, G. Yin, F. Chen, L. Lin and Y. Chen. Evaluation of triglyceride glucose index and homeostasis model of insulin resistance in patients with polycystic ovary syndrome. International Journal of Women’s Health, vol. 14, pp. 1821-1829, 2022. DOI: https://doi.org/10.2147/IJWH.S387942
10. D. Hiam. The Molecular Basis of Polycystic Ovary Syndrome: Genetics, Epigenetics, and Insulin Resistance, Victoria University, [Ph.D. Dissertation], 2018.
11. K. J. Chang, J. H. Chen and K. H. Chen. The pathophysiological mechanism and clinical treatment of polycystic ovary syndrome: A molecular and cellular review of the literature. International Journal of Molecular Sciences, vol. 25, no. 16, p. 9037, 2024. DOI: https://doi.org/10.3390/ijms25169037
12. Y. Tian, J. Li, S. Su, Y. Cao, Z. Wang, S. Zhao and H. Zhao. PCOS-GWAS susceptibility variants in THADA, INSR, TOX3, and DENND1A are associated with metabolic syndrome or insulin resistance in women with PCOS. Frontiers in Endocrinology, vol. 11, p. 274, 2020. DOI: https://doi.org/10.3389/fendo.2020.00274
13. A. L. Williams-Montgomery. The art of phlebotomy: Why is the order of draw so important? Journal of Allied Health, vol. 53, no. 3, pp. e187-e189, 2024.
14. J. P. Verma. Data Analysis in Management with SPSS Software. Springer Science and Business Media, Berlin, 2012. DOI: https://doi.org/10.1007/978-81-322-0786-3
15. N. Salari, A. Nankali, A. Ghanbari, S. Jafarpour, H. Ghasemi, S. Dokaneheifard and M. Mohammadi. Global prevalence of polycystic ovary syndrome in women worldwide: A comprehensive systematic review and meta-analysis. Archives of Gynecology and Obstetrics, vol. 310. no. 3, pp. 1303-1314, 2024. DOI: https://doi.org/10.1007/s00404-024-07607-x
16. Y. Shang, H. Zhou, M. Hu and H. Feng. Effect of diet on insulin resistance in polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism, vol. 105, no. 10, p. dgaa425, 2020. DOI: https://doi.org/10.1210/clinem/dgaa425
17. H. J. Teede, M. L. Misso, M. F. Costello, A. Dokras, J. Laven, L. Moran, T. Piltonen and R. J. Norman. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Human Reproduction, vol. 33, no. 9, pp. 1602-1618, 2018.
18. M. Sharifi, A. Saber, J. Moludi, Y. Salimi and A. Jahan-Mihan. The effects of portfolio moderate-carbohydrate and ketogenic diets on anthropometric indices, metabolic status, and hormonal levels in overweight or obese women with polycystic ovary syndrome: A randomized controlled trial. Nutrition Journal, vol. 23, no. 1, p. 152, 2024. DOI: https://doi.org/10.1186/s12937-024-01056-7
19. H. Hooshmandi, A. Ghadiri-Anari, A. M. Ranjbar, H. Fallahzadeh, M. Hosseinzadeh and A. Nadjarzadeh. Effects of licorice extract in combination with a low-calorie diet on obesity indices, glycemic indices, and lipid profiles in overweight/obese women with polycystic ovary syndrome (PCOS): A randomized, double-blind, placebo-controlled trial. Journal of Ovarian Research, vol. 17, no. 1, p. 157, 2024. DOI: https://doi.org/10.1186/s13048-024-01446-9
20. S. Kiconco, H. J. Teede, A. Earnest, D. Loxton and A. E. Joham. Menstrual cycle regularity as a predictor for heart disease and diabetes: Findings from a large population‐based longitudinal cohort study. Clinical Endocrinology, vol. 96, no. 4, pp. 605-616, 2022. DOI: https://doi.org/10.1111/cen.14640
21. V. Christodoulopoulou, E. Trakakis, V. Pergialiotis, M. Peppa, C. Chrelias, D. Kassanos and N. Papantoniou. Clinical and biochemical characteristics in PCOS women with menstrual abnormalities. Journal of Family and Reproductive Health, vol. 10, no. 4, pp. 184-190, 2016.
22. A. Ayar Madenli and G. Özer. Comparison of clinical andbiochemical parameters in the ovulatory and anovulatory phenotypes of polycystic ovary syndrome. Journal of Controversies in Obstetrics and Gynecology and Pediatrics, vol. 1, no. 4, pp. 90-94, 2023. DOI: https://doi.org/10.51271/JCOGP-0020
23. B. M. Zamila, H. Banu, M. S. Morshed, S. Shah, A. Begum, T. Sultana, N. Akhtar, M. Fariduddin, A. A. Saleh and M. A. Hasanat. Manifestations of polycystic ovary syndrome are similar regardless of the degree of menstrual cycle variation. International Journal of Human and Health Sciences, vol. 6, pp. 96-103, 2022. DOI: https://doi.org/10.31344/ijhhs.v6i1.383
24. S. Kwon, A. Heo and S. Chun. Triglyceride and glucose index for identifying abnormal insulin sensitivity in women with polycystic ovary syndrome. Obstetrics and Gynecology Science, vol. 66, no. 4, pp. 307-315, 2023. DOI: https://doi.org/10.5468/ogs.23103
25. M. Aghil, R. El-Megrabi, H. Alfaghi and R. Alrakhees. The relationship between insulin resistance and polycystic ovary syndrome in Libyan women. Khalij-Libya Journal of Dental and Medical Research, vol. 9, pp. 159-164, 2025. DOI: https://doi.org/10.47705/kjdmr.259203
26. A. Mansour, M. Mirahmad, M. R. Mohajeri-Tehrani, M. Jamalizadeh, S. Hosseinimousa, F. Rashidi, P. Asili and S. M. Sajjadi-Jazi. Risk factors for insulin resistance related to polycystic ovarian syndrome in Iranian population. Scientific Reports, vol. 13, no. 1, p. 10269, 2023. DOI: https://doi.org/10.1038/s41598-023-37513-2
27. E. Uysal, O. Tammo, E. Soylemez, M. Incebıyık, D. Filiz and M. Alci. Significance of measuring anthropometric and atherogenic indices in patients with polycystic ovary syndrome. BMC Endocrine Disorders, vol. 24, no. 1, p. 160, 2024. DOI: https://doi.org/10.1186/s12902-024-01701-6
28. A. Javidan, A. Azarboo, S. Jalali, P. Fallahtafti, S. Moayyed, M. Ghaemi, A. Tarafdari and S. Hantoushzade. The association between triglyceride-glucose index and polycystic ovary syndrome: A systematic review and meta-analysis across different populations. Journal of Ovarian Research, vol. 18, no. 1, p. 163, 2025. DOI: https://doi.org/10.1186/s13048-025-01717-z
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Zahraakhan M. Taher , Bakhtawar Z. Omer , Zheyan T. Younis, Dunya A. Asaad

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License [CC BY-NC-ND 4.0] that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).



